ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
Condition(s):Age-related Macular DegenerationLast Updated:October 17, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Age-related Macular DegenerationLast Updated:October 17, 2023Completed
Condition(s):Primary Mitochondrial DiseaseLast Updated:December 17, 2021Terminated
Condition(s):Friedreich AtaxiaLast Updated:August 14, 2023Active, not recruiting
Condition(s):Mitochondrial Myopathies; Mitochondrial Pathology; Mitochondrial DNA Mutation; Mitochondrial Diseases; Mitochondrial DNA Deletion; Mitochondrial DNA Depletion; Mitochondrial Metabolism Defect; Mitochondrial Complex I DeficiencyLast Updated:December 12, 2023Active, not recruiting
Condition(s):Chronic Heart FailureLast Updated:September 7, 2017Completed
Condition(s):Barth SyndromeLast Updated:March 9, 2022Completed
Condition(s):Heart FailureLast Updated:July 28, 2020Completed
Condition(s):Age-Related Macular DegenerationLast Updated:October 20, 2020Completed
Condition(s):Primary Mitochondrial MyopathyLast Updated:January 24, 2022Terminated
Condition(s):Mitochondrial Diseases; Barth SyndromeLast Updated:March 28, 2023Available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.